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Abstract 20 
Lipoteichoic acid (LTA) is an important cell wall component of Gram-positive bacteria 21 
and a promising target for the development of vaccines and antimicrobial compounds 22 
against Staphylococcus aureus. Here we demonstrate that mutations in the conditional 23 
essential ltaS (LTA synthase) gene arise spontaneously in an S. aureus mutant lacking 24 
the ClpX chaperone. A wide variety of ltaS mutations were selected and among these a 25 
substantial part resulted in premature stop-codons and other changes predicted to 26 
abolish LtaS synthesis. Consistent with this assumption, the clpX ltaS double mutants 27 
did not produce LTA, and genetic analyses confirmed that LTA becomes non-essential 28 
in the absence of the ClpX chaperone. In fact, inactivation of ltaS alleviated the severe 29 
growth defect conferred by the clpX deletion. Microscopic analyses showed that the 30 
absence of ClpX partly alleviates the septum placement defects of an LTA depleted 31 
strain, while other phenotypes typical of LTA-negative S. aureus mutants including 32 
increased cell size and decreased autolytic activity are retained. In conclusion, our 33 
results indicate that LTA has an essential role in septum placement that can be 34 
bypassed by inactivating the ClpX chaperone. 35 
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Importance 36 
Lipoteichoic acid is an essential component of the Staphylococcus aureus cell 37 
envelope, and an attractive target for the development of vaccines and antimicrobials 38 
directed against antibiotic resistant Gram-positive bacteria such as methicillin resistant 39 
S. aureus and vancomycin resistant Enterococci. In this study we show that the 40 
lipoteichoic acid polymer is only essential for growth of S. aureus as long as the ClpX 41 
chaperone is present in the cell. Our results indicate that lipoteichoic acid and ClpX play 42 
opposite roles in a pathway that controls two key cell division processes in S. aureus, 43 
namely septum formation and autolytic activity. The discovery of a novel functional 44 
connection in the genetic network that controls cell division in S. aureus may expand the 45 
repertoire of possible strategies to identify compounds or compound combinations that 46 
kill antibiotic resistant S. aureus. 47 
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Introduction 48 
Staphylococcus aureus remains a leading cause of hospital- and community-acquired 49 
skin and soft tissue infections as well as of life-threatening invasive diseases (1). While 50 
β-lactams like penicillin and methicillin were once effective antibiotics in treating 51 
staphylococcal infections, the spread of methicillin-resistant S. aureus (MRSA) has 52 
made treatment increasingly difficult (2). The profound ability of S. aureus to acquire 53 
resistance towards clinically relevant antibiotics has prompted an interest in identifying 54 
targets that can be used for the development of novel antibiotics with activity against 55 
MRSA (3). 56 
The cell wall polymer lipoteichoic acid (LTA) has been proposed as an attractive target 57 
for the development of both vaccines and antimicrobial compounds directed against S. 58 
aureus (reviewed in Reference 4). LTA is found abundantly in the cell wall of many 59 
gram-positive bacteria and is defined as an alditolphosphate-containing polymer that is 60 
attached to the outside of the cytoplasmic membrane via a lipid anchor (4). Gram-61 
positive bacteria synthesize different types of LTA that, based on their chemical 62 
structures, are grouped into different types (4, 5). S. aureus, like many other Firmicutes, 63 
produces type I LTA consisting of an unbranched 1-3 linked glycerolphosphate (GroP) 64 
backbone chain. The addition of GroP residues to the tip of the growing LTA-chain 65 
takes place at the outer surface of bacterial membranes, and is catalyzed by the LTA 66 
synthase (LtaS) enzyme (6). The exact cellular function of LTA remains unknown, but 67 
importantly LTA is essential for growth of S. aureus under standard laboratory growth 68 
conditions (6, 7). Depletion of LtaS results in cell enlargement, aberrant positioning of 69 
division septa, and ultimately cell lysis, pointing to a functional link between LTA and the 70 
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cell division process (6, 8). Consistent with this idea, LtaS of S. aureus was recently 71 
shown to interact with numerous early and late cell-division proteins as well as enzymes 72 
involved in peptidoglycan synthesis (9). In the rod-shaped Firmicutes Bacillus subtilis 73 
and Listeria monocytogenes, inactivation of LTA synthesis also interferes with cell 74 
division which is evident by cell filamentation and delocalization of the FtsZ cell division 75 
initiator protein (10, 11). A functional link between LTA synthesis and cell division 76 
therefore seems to be conserved within the family of Firmicutes. Other observations, 77 
however, indicate that the essential role of LTA in S. aureus is, at least partly, related to 78 
osmoprotection. First, LTA-deficient S. aureus strains can be propagated under 79 
osmotically stabilizing conditions (8). Secondly, growth of an S. aureus ltaS mutant is 80 
rescued by inactivation of GdpP, a phosphodiesterase that hydrolyzes the essential 81 
signaling molecule cyclic-di-AMP, which is implicated in the control of potassium 82 
transport, an important ion in osmotic homeostasis (7, 8). In fact, type I LTA was 83 
recently proposed to share functionality with the osmoregulated periplasmic glucans 84 
(OPG) that accumulate in the periplasm of gram-negative bacteria under low-osmolarity 85 
conditions (4). 86 
The highly conserved ClpX chaperone has a dual role in the cell, as it both targets 87 
proteins for degradation by associating with the ClpP peptidase, and independently of 88 
ClpP, facilitates protein folding and interactions (12). In S. aureus, inactivation of clpX 89 
severely reduced virulence in both localized and systemic models of infections 90 
suggesting that ClpX is indispensable for S. aureus pathogenesis (13, 14).  Consistent 91 
with this observation, ClpX controls, by an unknown mechanism, the transcription of a 92 
number of major virulence genes, and the translation of Protein A and the global 93 
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virulence regulator, Rot (14–16). ClpX belongs to the Hsp100 family of heat shock 94 
proteins that become critical during heat stress and other stresses conferring protein 95 
folding stress (12). Surprisingly, inactivation of clpX in S. aureus improved survival at 96 
high temperatures indicating that ClpX does not function as a classical heat shock 97 
chaperone in this bacterium (14). Consistent with this notion, clpX transcription is not 98 
inducible by heat stress in S. aureus (14). Inactivation of ClpX in S. aureus did, 99 
however, severely impair growth at 30°C and below (14). The molecular mechanism 100 
underlying this phenotype is unknown, and is not shared by a mutant lacking ClpP, 101 
suggesting that it is the ClpP-independent chaperone activity of ClpX that is important 102 
for growth of S. aureus at 30°C (14). In the present study we used a whole genome 103 
sequencing approach to characterize compensatory mutations that arise spontaneously 104 
with high frequency when the clpX deletion mutant is propagated at 30°C and below. 105 
Intriguingly, the most frequent type of detected mutations was loss-of-function mutations 106 
in the ltaS gene. Essentiality of LtaS in the isogenic wild-type strains was confirmed, 107 
thus demonstrating that S. aureus can grow without LTA in the absence of the ClpX 108 
chaperone. To gain insight into the mechanisms underlying the requirement for LTA, a 109 
phenotypic characterization of the clpX ltaS double mutant was performed. From this 110 
analysis we conclude that disruption of clpX compensates for the absence of LTA by a 111 
c-di-AMP independent pathway that appears to be linked to cell division. 112 
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Results 113 
Inactivation of ClpX confers a severe growth defect at 30°C that is independent of 114 
the strain background and of ClpP 115 
Previously we reported that an S. aureus clpX mutant forms colonies of very reduced 116 
size at 30°C (14). The original clpX mutant was constructed in the laboratory S. aureus 117 
strain 8325-4 that has very low activity of the SigB stress-response regulator (14, 17). 118 
We therefore first set out to assess if the cold-sensitive phenotype of the clpX mutant is 119 
conserved in SigB proficient S. aureus strains. The effect on growth of a clpX deletion 120 
was examined in more detail in four different backgrounds namely the widely used 121 
laboratory strains 8325-4 and Newman, the low-passage clinical isolate SA564, and 122 
JE2, an erythromycin sensitive derivative of the community acquired MRSA strain, 123 
USA300 LAC. In all strain backgrounds, the clpX deletion mutants formed colonies that 124 
were slightly smaller than wild-type colonies at 37°C or temperatures above (Fig. 1A 125 
and data not shown). When the temperature was reduced to 30°C or 25°C, the clpX 126 
mutants formed barely visible colonies demonstrating that deletion of clpX confers a 127 
growth defect to S. aureus that increase with decreasing temperatures in all strain 128 
backgrounds (Fig. 1A and data not shown).  Introduction of a clpX complementing 129 
plasmid enables the clpX mutant strain to form colonies of wild-type size (Fig. 1B).  130 
Growth assays in liquid medium at 30°C showed that the clpX mutants exhibited 42 - 131 
67% lower exponential growth rates (depending on strain background; Fig. 1C), and 132 
that the clpX mutant reached a much lower final density (CFUs per ml or OD; Fig. 1D 133 
and 1E) independently of the size and growth status of the inoculum (Fig. S1). At 37°C 134 
the growth defect of the clpX mutants was much less severe, as the cultures reached 135 
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roughly the same final CFUs per ml as the respective wild type strains and the 136 
exponential growth rates were only slightly reduced (14 - 25%; Fig. 1C and 1D). 137 
ClpX can associate with ClpP to form the ClpXP protease. To investigate if ClpX 138 
contributes to growth at low temperatures via a ClpP dependent pathway, we examined 139 
the effect of a clpP deletion on growth. We found that although the clpP mutants grew 140 
slower than the parental strains, similar reductions in exponential growth rates were 141 
observed at 30°C (27 - 29%) and 37°C (22 - 33%; Fig. 1C). Additionally, the 142 
temperature had little effect on endpoint CFUs per ml (Fig. 1D). Thus, the growth defect 143 
conferred by the clpP deletion does not mimick the temperature-dependent effect of the 144 
clpX deletion, suggesting that it is the ClpP-independent chaperone activity which is 145 
required for growth at temperatures below the optimum. The ClpC chaperone is an 146 
alternative substrate recognition factor for ClpP, and to rule out that the impaired growth 147 
of the clpX mutant is caused by an abnormal activity of ClpCP (due to the absence of 148 
ClpX), we constructed an S. aureus 8325-4 clpX clpP double mutant (KB1506) and 149 
compared its growth with the 8325-4 clpX single mutant. As seen in Fig. 1E the clpX 150 
clpP double mutant exhibited a growth defect similar to that of the clpX mutant, 151 
supporting the notion that the clpX growth phenotype is not mediated via ClpCP. In 152 
summary, inactivation of the ClpX chaperone activity in S. aureus confers a cold 153 
sensitive phenotype to S. aureus that is independent of ClpP and of the strain 154 
background. 155 
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Loss-of-function mutations in the ltaS gene arise spontaneously in clpX mutants 156 
grown at temperatures below optimum 157 
When the clpX mutant strains are plated at 30°C, larger colonies consistently appear 158 
among the very small colonies (Fig. 2A), indicating that the growth defect associated 159 
with lack of ClpX can be alleviated genetically by the acquisition of spontaneous 160 
suppressor mutations. The frequency of large suppressor colonies in cultures of the 161 
clpX mutants after 24 h of growth at 30°C was 0.12 ± 0.06 in the 8325-4 clpX 162 
background, and 0.92 ± 0.04 in the SA564 clpX background. One suspected suppressor 163 
mutant, strain 564-25-2, with restored growth at 30°C (Fig. 1A and 2B) was chosen for 164 
Illumina genome sequencing. The sequencing analysis revealed that strain 564-25-2 165 
deviated from the parental SA564 clpX strain by only one single nucleotide 166 
polymorphism (SNP) located in the ltaS gene and causing a H476Q substitution in the 167 
lipoteichoic acid (LTA) synthase enzyme, LtaS. Interestingly, the H476 residue was 168 
previously found to be essential for LtaS activity (18). To examine if mutations in ltaS 169 
were common among the clpX suppressor colonies, the ltaS gene was sequenced in a 170 
number of the suppressor mutants. The suppressor mutants were selected either 171 
directly on solid media without a culturing step, or by passaging independent cultures of 172 
the 8325-4 clpX strain at 30°C until large suppressor colonies accounted for at least 173 
90% of the CFU count (details are described in Materials and Methods). Remarkably, 174 
mutations in ltaS were identified in seven of the ten independent 8325-4 clpX cultures 175 
as well as in a large number of the remaining suppressor strains selected in both the 176 
8325-4 and SA564 strain backgrounds. As depicted in Fig 3A, these mutations resulted 177 
in premature stop-codons, amino acid substitutions, and in-frame deletions. 178 
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The ltaS mutations were predicted to be loss-of-function mutations based on the 179 
selection of a mutation changing the essential histidine at position 476 to a glutamine, 180 
and the frequent selection of mutations resulting in premature stop-codons (18). 181 
Consistent with this prediction, the LTA polymer was absent from the two representative 182 
strains 83-25C (LtaS382STOP isolated in the 8325-4 clpX background) and 564-25-2 183 
(LtaSH476Q; Fig. 3B). The LTA immunoblot showed a stronger LTA signal in the 8325-4 184 
clpX mutant, indicating that ClpX impacts LTA expression; however, this difference was 185 
not reproducible (data not shown) consistent with our experience that LTA immunoblots 186 
should be interpreted qualitatively rather than quantitatively. LtaS expression was not 187 
altered by inactivation of either clpX or clpP but a strong LtaS band was detected in 188 
strain 564-25-2 confirming previous results (18) that the non-functional LtaSH476Q variant 189 
is expressed in higher amounts than the wild-type LtaS (Fig 3B and Table S3). 190 
The loss-of-function mutation in ltaS was the only genetic change introduced in the 191 
genome sequenced 564-25-2 suppressor mutant, strongly suggesting that inactivation 192 
of LtaS results in the improved growth of the clpX mutant. In support hereof, the growth 193 
defect of the SA564 clpX strain was restored to a similar extent by disrupting the ltaS 194 
gene with an ltaS::erm marked deletion introduced by phage transduction (Fig 3C). We 195 
conclude therefore that inactivation of the conditionally essential LtaS synthase 196 
alleviates the growth defect caused by inactivation of the ClpX chaperone. 197 
LTA becomes non-essential in cells devoid of ClpX chaperone activity 198 
LTA has been reported to be essential for growth of S. aureus at 37°C. Therefore we 199 
were surprised to find that the two clpX suppressor-mutants confirmed to harbor loss-of-200 
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function mutations in ltaS improved growth of the clpX mutant not only at 30°C but also 201 
at 37°C; the clpX ltaS double mutants were, however, not capable at growing at 44°C 202 
(Fig. 1A). The finding that the LTA-negative suppressor mutants grow well at 37°C 203 
indicates that LTA becomes non-essential in S. aureus cells lacking ClpX. To verify this, 204 
we performed a genetic linkage analysis to test whether the wild-type clpX allele 205 
(marked by inserting the ermB gene in a nearby non-coding sequence (19)) can be 206 
back-transduced into the clpX ltaS suppressor mutant. As shown in Table 1, the wild-207 
type clpX gene was not co-transduced along with ermB into the LTA-negative clpX 208 
strains, whereas we obtained a high frequency of co-transduction when using LTA-209 
positive clpX mutant strains as recipients. This result is highly significant (p < 0.0005) 210 
indicating that LTA is indeed essential under the conditions used in this study, and that 211 
LtaS becomes non-essential in the absence of the ClpX chaperone. To confirm this 212 
result, plasmid pKB1469 expressing ClpX under the control of an anhydrotetracycline 213 
(AHT) inducible promoter was introduced into strain 83-25C. As predicted, this strain 214 
lost viability upon induction of ClpX expression at 37°C showing that LtaS is essential in 215 
a ClpX-positive strain (Fig. 3D). In contrast, no effect on viability was observed when 216 
expression of ClpX was induced at 30°C (Fig.3D) which is in line with the finding by Oku 217 
et al. (8) that LtaS is non-essential at 30°C.  218 
Inactivation of ClpX compensates for the absence of LTA by a novel c-di-AMP 219 
independent pathway 220 
An S. aureus gdpP mutant can, similarly to a clpX mutant, grow without LTA (7). The 221 
GdpP phosphodiesterase cleaves the second messenger c-di-AMP, and consequently 222 
the intracellular concentration of c-di-AMP is significantly increased in gdpP mutant 223 
 12
strain (7). Interestingly, the S. aureus clpX mutant shares some phenotypes with a gdpP 224 
mutant, namely a decrease in cell size, a small increase in peptidoglycan cross-linking 225 
(7, 19), and as shown here, the ability to grow without LTA. To assess if these shared 226 
phenotypes correlated with increased intracellular c-di-AMP levels in the clpX mutant, 227 
we quantified c-di-AMP levels in cytoplasmic extracts from cultures of strains SA564 228 
and JE2, the corresponding clpX mutant strains, and the suppressor strain 564-25-2 229 
(ltaS clpX) using an LC-MS/MS method (7). The results (Fig. 4) showed no significant 230 
differences in cellular levels of c-di-AMP between the wild types and the mutant strains, 231 
suggesting that inactivation of clpX bypasses the requirement for LTA by a c-di-AMP 232 
independent pathway. 233 
Lack of ClpX improves septum formation in LTA depleted cells 234 
Depletion of LtaS in S. aureus confers a number of distinct phenotypes including 235 
morphological changes such as an increase in cell size, misplacement of division septa, 236 
and a tendency to clump (6). Similar changes were reported when an RN4220 ltaS 237 
mutant was grown under conditions permissive for growth (8). Inactivation of clpX on 238 
the other hand did not impact septum localization but resulted in significantly smaller 239 
cells with a thickened cell wall (19). The finding that LtaS becomes non-essential in a 240 
clpX mutant strain, prompted us to investigate if the absence of the ClpX chaperone 241 
counteracted some of the morphological phenotypes of LtaS depleted cells. Light and 242 
transmission electron microscopy (TEM) of the wild type, the clpX single mutant, and 243 
the clpX ltaS double mutant grown at 30°C or 37°C showed that the majority of the clpX 244 
ltaS double mutant cells exhibit wild-type placement of the division septa, that is, 245 
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septum formation that occurs at the mid-cell and mostly perpendicular to previous 246 
division planes (Fig. 5A, 5B and S2). The clpX ltaS cells were, however, larger and 247 
more irregularly shaped than wild-type cells or clpX single mutant cells, and additionally 248 
the cell wall was thicker, more irregular, and had a fuzzier appearance (Fig 5B). To 249 
directly investigate the effect on cell division of depleting LTA in cells that lack clpX, S. 250 
aureus strains with IPTG inducible ltaS expression were created in either an 8325-4 251 
wild-type (8325-4-iltaS) or an 8325-4 clpX (8325-4-clpX-iltaS) genetic background.  As 252 
expected, in the absence of IPTG and hence ltaS expression, cells with an intact clpX 253 
gene stopped growing whereas cells with a disrupted clpX gene were able to continue 254 
growth, corroborating the above conclusion that LTA becomes non-essential when ClpX 255 
is inactivated (Fig. S3). Extensive cell wall synthesis at the division site was observed in 256 
the presence of LTA both in the presence and absence of an intact clpX gene (Fig. 5A, 257 
S4 and S5). Depletion of LTA also resulted in cell enlargement regardless of clpX status 258 
(Fig. 5A, S4, and S5). However, while LTA depletion led to a reduction in visible septum 259 
formation in the wild-type background, septum formation was still prevalent after LTA 260 
depletion in the clpX background (Fig. 5A, S6, and S7).  In summary, inactivation of 261 
clpX appears to rescue the reduced ability of LTA deficient cells to lay down the septum 262 
correctly, whereas lack of clpX does not counteract other phenotypes associated with 263 
the lack of LTA: namely a larger cell size, thicker and more irregular cell wall, and cell 264 
clustering. 265 
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Inactivation of LtaS decreases peptidoglycan crosslinking and increases 266 
susceptibility to vancomycin and cefoxitin 267 
Inactivation of clpX causes a small increase in peptidoglycan cross-linking and 268 
decreases susceptibility to several types of antibiotics targeting the cell wall, and we, 269 
hence, speculated that the cellular changes underlying these phenotypes might be 270 
correlated to the ability of the clpX mutant to tolerate LTA deficiency (19). To examine 271 
the changes in cell wall properties in more detail we compared the muropeptide profiles 272 
of SA564 wild-type, clpX, and clpX ltaS mutant cells. This analysis revealed that while 273 
the peptidoglycan profiles from SA564 wild-type and clpX mutant cells are very similar, 274 
the peptidoglycan from the LTA deficient clpX ltaS mutant was characterized by a 275 
severe reduction in highly cross-linked muropeptides (>8-mers), and a concomitant 276 
increase in the relative fraction of dimers to octamers (Fig 5C). Next, we determined the 277 
susceptibilities of the strains towards antibiotics targeting the cell envelope. This 278 
analysis revealed that the clpX ltaS double mutant is more sensitive towards cefoxitin 279 
and vancomycin than the clpX mutant and the wild-type strains, and slightly more 280 
sensitive to oxacillin (Table 2). In contrast, the ltaS mutation did not affect susceptibility 281 
towards imipenem and ertapenem that both belong to the carbapenem class of β-282 
lactams. As shown previously (19), the clpX deletion had only minor effects on the 283 
susceptibility to oxacillin and daptomycin in the strains SA564 and 8325-4, and no effect 284 
on susceptibility to cefoxitin and vancomycin. Taken together, these results indicate that 285 
the introduction of loss-of-function mutations in ltaS concomitantly decrease 286 
peptidoglycan cross-linking and susceptibility to some cell wall targeting antibiotics. The 287 
effect of the clpX and ltaS mutations varied greatly with the type of antibiotic, and there 288 
 15
was no trend supporting that the cellular changes responsible for decreasing antibiotic 289 
susceptibility of the clpX mutant are contributing to the ability of the clpX mutant to grow 290 
in the absence of LTA. 291 
The LTA and ClpX have opposite roles in determining the level of surface-bound 292 
autolysins 293 
LTA is critical for maintaining normal levels of peptidoglycan hydrolase activity, and 294 
binding of the major S. aureus autolysin, Atl, to the cell wall seems to involve direct 295 
interactions between Atl and LTA (20). We therefore examined autolytic activity of our 296 
strains and found that the autolytic activity of the clpX ltaS double mutant was greatly 297 
reduced in a Triton X-100 autolysis assay, demonstrating that the clpX ltaS double 298 
mutant, similar to LTA depleted cells, has reduced autolytic activity (Fig. 6A). To follow 299 
up on this finding, a zymographic analysis was performed. In the zymographic analysis 300 
the activity of the major autolysin, Atl, is visible in multiple bands reflecting that Atl is a 301 
bifunctional murein hydrolase that is produced as a 138-kDa precursor protein, 302 
sequentially cleaved to generate 115- and 85-kDa intermediate products, and further 303 
processed to generate a 62-kDa N-acetylmuramyl-L-alanine amidase (AM) and a 51-304 
kDa N-acetylglucosaminidase (GL; Fig. 6B). Consistent with the Triton-X-autolysis 305 
assay, the zymographic profile of cell extracts derived from the clpX ltaS double mutant 306 
demonstrated that the intensity of Atl bands was reduced in the clpX ltaS double 307 
mutant, when compared to the profiles of wild-type, or clpX mutant cells. The only 308 
exception is the band originating from the 62-kDa mature AM that has the same 309 
intensity as in wild-type extracts. In contrast, inactivation of clpX alone increased the 310 
intensity of this band and an 85-kDa variant of Atl (Fig. 6B). In the zymographic 311 
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analysis, activity of the Sle1 autolysin is also clearly visible. As previously reported, the 312 
level of Sle1 is a substrate of ClpXP and consequently present at elevated levels in clpX 313 
and clpP mutant cells (21). Strikingly, the level of Sle1, similar to the 62-kDa mature 314 
AM, was again reduced to wild-type levels in the clpX ltaS double mutant. 315 
S. aureus encodes a number of additional enzymes predicted to possess autolytic 316 
activity, but their activity is not visible in the zymographic analysis. In order to 317 
investigate the general impact of ClpX and LTA on the levels of autolytic enzymes 318 
bound to the cell surface, the surface proteome (“surfacome”) was analyzed by trypsin 319 
shaving followed by MS identification. The surfacome analyses identified two other 320 
predicted autolysins, SceD and Aaa, in addition to Atl that were identified with the 321 
highest identification scores in the surfacome of the single clpX mutant strain (Table 322 
S2), suggesting that the three autolysins are expressed at higher levels, or that their 323 
stability is increased at the cell surface of the clpX mutant compared to the wild-type or 324 
the clpX ltaS strains. This confirms that ClpX has a negative impact on the level of Atl 325 
and two other surface bound autolysins. The comparable identification scores of these 326 
three autolysins shaved from wild-type and clpX ltaS double mutant cells further 327 
supports that inactivation of LtaS in cells lacking ClpX reduces the amount of these 328 
surface-bound autolysins back to wild-type levels. Taken together, our results suggest 329 




LTA is an abundant cell wall polymer that has attracted interest as a novel antibacterial 333 
target owing to its essential role for growth of S. aureus (22). Moreover, LTA seems to 334 
have an important role in resistance to β-lactams, as MRSA strains can be re-sensitized 335 
to some β-lactams by reducing expression of the ltaS gene (23). Thus, compounds 336 
targeting LTA synthesis may have the additional advantage that they can be used in 337 
combination with β-lactams to effectively combat MRSA. 338 
The exact role of LTA remains unknown, and the pleiotropic phenotypes associated with 339 
depletion of LTA have represented a challenge for dissecting why LTA is conditional 340 
essential for growth of S. aureus. In the present study we show that mutations 341 
abolishing the function of LtaS arise spontaneously in an S. aureus mutant lacking the 342 
ClpX chaperone. The finding that the combined deletion of the ltaS and clpX genes 343 
results in cells that grow almost as well as wild-type cells, despite that each of the single 344 
deletions confers a severe growth defect to S. aureus cells, indicates that ClpX and LTA 345 
have opposite roles in a pathway that is critical for growth of S. aureus. The effect of 346 
deleting either the clpX or the ltaS gene is strongly dependent on temperature: deletion 347 
of clpX impairs growth severely at 30°C and mildly at 37°C and, vice versa, deletion of 348 
ltaS results in loss of viability at 37°C but for some strains not at 30°C.  349 
Phenotypic analysis revealed that the clpX ltaS double mutant retained most of the 350 
hallmark phenotypes associated with LTA depletion including morphological changes 351 
such as enlarged cell size, a thickened, irregular cell wall, and impaired cell separation 352 
following cell division. The latter phenotype has been explained by the substantially 353 
reduced autolytic activity in cells lacking LTA (8). Interestingly, here we showed that a 354 
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number of autolysins including the major autolysin Atl are more abundant in the 355 
surfacome of S. aureus cells lacking ClpX, and that the level of autolysins are reduced 356 
to wild-type level or lower by the subsequent inactivation of LtaS. Taken together our 357 
results show that LTA and ClpX have opposite roles in determining the level of surface-358 
bound autolysins. Hence, one possible scenario is that the dual inactivation of ClpX and 359 
LtaS may help to balance the aberrant autolytic activity caused by the single inactivation 360 
of either ClpX or LtaS. However, the validity of this hypothesis is questioned by our 361 
finding that the clpX ltaS double mutant, despite the near wild-type expression of Atl and 362 
other autolysins, retained phenotypes associated with reduced expression of autolysins 363 
such as a deficiency in cell separation and very low autolytic activity in a Triton-X-100 364 
autolysis assay. 365 
LTA depletion is also characterized by reduced cell wall synthesis at the septum and 366 
aberrant positioning of division septa (7, 8). Intriguingly, we showed here that in LTA 367 
depleted cells that lack a functional clpX gene, extensive septum formation was 368 
observed at mid-cell suggesting that inactivation of clpX to some extent alleviates the 369 
septum-placement defects associated with LTA deficiency. The partly restored septum 370 
formation in cells lacking both ClpX and LTA implies that cell division is central in 371 
understanding the functional link between ClpX and LTA activity. In almost all bacteria, 372 
cell division is orchestrated by the tubulin homologue, FtsZ, which polymerizes to form a 373 
ring-like structure, the Z-ring that establishes the location of the division site (24). The Z-374 
ring is tethered to the cell membrane by the essential FtsA protein that also has a role in 375 
the formation of larger FtsZ bundles, as well as for recruiting downstream cell division 376 
proteins (24). It has been found that the ClpX chaperone modulates FtsZ polymer 377 
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dynamics in bacteria as diverse as Escherichia coli, B. subtilis, and Mycobacterium 378 
tubercolosis suggesting that ClpX has a widely conserved role in cell division by 379 
interacting directly with FtsZ (25–27). Similarly, several observations indicate that LtaS 380 
also has a direct role in cell division. First, LtaS accumulates at the division site where it 381 
has been proposed to be part of a large multi-enzyme complex containing early stage 382 
division proteins like FtsA, as well as late stage cell division proteins (9). Additionally, S. 383 
aureus cells depleted for both LTA and WTA lose the ability to establish the Z-ring (28). 384 
The literature therefore supports the scenario that both LTA and ClpX have a direct role 385 
in cell division. Our finding that the combined inactivation of LtaS and ClpX abolished 386 
the growth-defect conferred by each of the single mutations suggests that ClpX and 387 
LTA have antagonistic roles in the cell division process of S. aureus. 388 
 389 
In conclusion, we have shown that the LTA cell wall polymer becomes non-essential for 390 
growth of S. aureus if cells are devoid of ClpX chaperone activity by a novel c-di-AMP 391 
independent pathway. The presented data indicate that ClpX and LTA have opposing 392 
roles in the coordination of two key cell division processes S. aureus namely septum 393 
formation and control of autolytic activity thereby providing novel insight into the function 394 
of this important cell wall polymer of Gram-positive bacteria. 395 
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Materials and Methods 396 
Bacterial strains and growth conditions 397 
Strains used in this study are listed in Table S1. Strain constructions are described in 398 
Supplementary Materials and Methods (Text S1). E. coli strains were cultured in Luria 399 
broth (LB) at 37°C or 30°C, or on LB medium solidified with 1.5% w/v agar. S. aureus 400 
strains were cultured in tryptic soy broth (TSB) at 37°C or 30°C with aeration, or on TSB 401 
medium solidified with 1.5% w/v agar (TSA). When inoculating clpX deletion strains, 402 
care was taken to avoid visibly larger colonies containing potential suppressor mutants. 403 
S. aureus JE2-derived strains were obtained from the Network of Antimicrobial 404 
Resistance in Staphylococcus aureus (NARSA) program (supported under NIAID/NIH 405 
contract HHSN272200700055C).  406 
 407 
Growth curves and growth rate calculations 408 
Growth of S. aureus strains was assessed by measuring optical density (OD600) of 409 
cultures grown in Erlenmeyer flasks or in a Bioscreen C instrument (Oy Growth Curves 410 
Ab Ltd, Finland), and by determining the number of CFUs per ml in cultures grown in 411 
Erlenmeyer flasks. Overnight cultures were grown in TSB at 37°C. For growth curves in 412 
Erlenmeyer flasks, overnight cultures were diluted 1:200 in 30 ml TSB giving a starting 413 
OD600 of approx. 0.015 - 0.03, and incubated with aeration at 30°C or 37°C with or 414 
without antibiotics as indicated. OD600 values were determined at 1 h intervals and 415 
CFUs per ml culture were determined at 2h intervals by performing serial dilutions in 416 
 21
0.9% w/v NaCl and plating 100 μl on TSB plates. Plates were then incubated at 37°C 417 
and colonies were enumerated after overnight growth. The colony size distribution in 418 
clpX cultures was clearly bimodal allowing easy distinction between small and larger 419 
presumed suppressor colonies. For growth in the Bioscreen C instrument overnight 420 
cultures were diluted in 300 μl TSB to an OD600 of approx. 0.001, and OD600 was 421 
measured every 5 min with 20 seconds of shaking before each measurement. 422 
All exponential growth rates were determined by growing the relevant strains in a 423 
Bioscreen C instrument as described above. The growth rates were automatically 424 
calculated by applying a custom R script (29) using a linear regression function kindly 425 
provided by the Botstein laboratory 426 
(http://www.princeton.edu/genomics/botstein/protocols/Growth-Rate-Using-R.pdf). In 427 
short, OD600 values were log-transformed and linear regressions were determined for 428 
each data point in the OD600 interval from 0.02 to 0.12 based on a window containing 15 429 
data points. The exponential growth rate was identified as the maximal slope of the 430 
linear regressions. The script for calculation of growth rates was validated on simulated 431 
growth data obtained from the logistic growth equation for growth yield as a function of 432 
time (t), growth rate (μ), and lag time (30). The standard deviation was calculated using 433 
values from different biological replicates. Statistical significance was calculated using 434 




Genetic suppressor analysis 438 
SA564 and 8325-4 clpX mutants were streaked for single colonies on tryptic soy agar 439 
plates and incubated at 37°C overnight. Several small colonies were then resuspended 440 
in 0.9% (w/v) NaCl and dilutions were spread on TSA plates that were incubated at 441 
25°C, 30°C or 37°C. Colonies that appeared visibly larger than the background colonies 442 
were colony purified twice and stored. In addition, ten independent overnight cultures of 443 
8325-4 clpX grown at 37° were diluted 1:1000 into 1 ml fresh TSB medium, and 444 
incubated with aeration at 30°C. After 24 hours, the cultures were transferred again to 445 
fresh medium by a 1:1000 dilution. Each day bacteria were plated on TSA at 30°C to 446 
determine the proportion of large suppressor colonies. After two passages at 30°C, all 447 
cultures contained at least 90% suppressors, and one large colony from each culture 448 
was purified and stored. The ltaS gene was amplified by PCR with primers KB71F and 449 
KB71R on genomic DNA prepared from 26 suppressor mutants isolated in the SA564 450 
and 8325-4 backgrounds, and sequenced by capillary sequencing using primers 451 
KB71F, KB73F and KB71R. 452 
Co-transduction experiment 453 
KB1241 was used as donor for bacteriophage Φ11 transduction into strains 8325-454 
4ΔclpX, 83-25C and KB1262, or bacteriophage Φ85 transduction into strains 455 
SA564ΔclpX and 564-25-2, selecting for erythromycin (5 mg/l) resistance. The presence 456 
of the ermB gene was confirmed in the transductants by PCR with the primers KB76F 457 
and KB76R (19) prior to testing for co-transduction of the wild-type clpX allele by PCR 458 
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with the primers saclpx385f and saclpx2447r (14). Statistical significance was calculated 459 
using Pearson's Chi-squared test. 460 
SNP detection 461 
One of the obtained suppressor mutants in the SA564 clpX genetic background (564-462 
25-2) was chosen for SNP detection. Genomic DNA was prepared from overnight 463 
cultures of the SA564 clpX strain and the suppressor strain 564-25-2 grown in TSB at 464 
37°C, and sequenced on an Illumina Hi-Seq 2000 instrument (Fasteris, SA, Geneva, 465 
Switzerland). The sequencing reads obtained by Illumina sequencing of SA564 clpX 466 
and the suppressor mutant 564-25-2 were aligned to the assembled SA564 genome 467 
(GenBank accession numbers CP010890 and CP010891 for chromosome and plasmid, 468 
respectively; Reference 31) using Bowtie2 (version 2.2.3, default parameters; 469 
Reference 32). The sequences have been submitted to the European Nucleotide 470 
Archive under accession number PRJEB8687. Alignments were converted to sorted, 471 
indexed binary alignment map (BAM) files, and SNPs and indels were called with 472 
SAMtools and BCFtools (version 1.1, default parameters; Reference 33). Using 473 
BEDtools (version 2.21.0; Reference 34) the average read coverage was calculated to 474 
695 for strain 564-25-2 and 410 for strain SA564 ΔclpX. The sequencing reads from 475 
SA564 clpX or 564-25-2 covered the whole reference genome except for the expected 476 
clpX deletion in both strains (position 2066206 to 2066840) and a 14-nt deletion in an 477 
intergenic region (position 2273962 to 2273975) in both strains. The SA564 reference 478 
genome was annotated with the RAST server (35), and annotations and calculated 479 
amino acid changes were assigned to the variant set using a custom R script. Variants 480 
were excluded if the quality score for the base call was <100, or if the phred-scaled p-481 
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value using Fisher's exact test for strand bias was >200 for indels or >60 for SNPs. The 482 
filtered variants were verified by capillary sequencing using appropriate PCR primers 483 
(Table S2). By this method, one SNP (A2274642T) in the tRNA-Leu-CAA gene was 484 
identified between the reference genome and our SA564 wild type, no SNPs were 485 
identified between the SA564 wild type and the SA564 clpX mutant, and one SNP 486 
(C1082972A) in the ltaS gene (LtaSH476Q) was identified between strain 564-25-2 and 487 
the SA564 clpX mutant. 488 
 489 
LtaS depletion and fluorescence microscopy 490 
S. aureus strains 8325-4, 8325-4-ΔclpX, and 8325-4-ΔclpXltaSstop were grown overnight 491 
at 37°C in TSB. Strains 8325-4-iltaS and 8325-4ΔclpX-iltaS were grown in TSB with 492 
erythromycin 10 μg/ml and 1 mM isopropyl β-d-thiogalactosidase (IPTG). The following 493 
day, bacteria from a 1 ml culture aliquot were harvested and washed three times with 494 
1 ml TSB. Next, 6 ml TSB (substituted where necessary with 1 mM IPTG) was 495 
inoculated with 60 µl washed bacterial suspensions (1:100 dilution) and cultures 496 
incubated at 37°C with shaking. The OD600 values were recorded every two hours for 8 497 
hours. To maintain the culture in log phase, at the 4 h time point the cultures were again 498 
back diluted 1:100 into 5 ml fresh TSB (when required substituted with 1 mM IPTG) and 499 
growth continued for an additional 4 hours. The average OD600 values and standard 500 
deviations from three independent experiments were plotted. At the 4 h time point, 1 ml 501 
of culture was removed and prepared for the detection of LTA by western blot.  502 
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For microscopy, strains were grown as described above with the exception that strain 503 
NCTC8325-4-iltaS propagated in the absence of IPTG was diluted 1:10 at the 4 h point, 504 
to obtain sufficient material for the subsequent microscopy analysis. At the 7 h time 505 
point, bacteria from a 2 ml of culture were harvested by centrifugation for 2 minutes at 506 
17,000 x g. Cells were washed 3 times with PBS pH 7.4. The cells were suspended in a 507 
volume of PBS to give a final OD600 of 3. Coverslips were prepared in advance by 508 
coating them with 100 μl of a 0.1% polylysine solution and washing 4 times with PBS pH 509 
7.4. Next, 100 μl of cells were placed on the coverslip for 3 minutes and washed 3 times 510 
with PBS. Finally, 100 μl of a 1 μg/ml vancomycin-BODIPY (Molecular Probes) solution 511 
was added to the immobilized bacteria and incubated for 5 to 20 minutes and 512 
subsequently washed 3 times with PBS. The coverslips were mounted onto a slide 513 
containing 20 μl of Vectashield (Vector Laboratories). Cells were visualized on a Zeiss 514 
Axio Imager A2, using a GFP filter and images were captured with an AxioCam MRc 515 
Rev.3 camera. 516 
 517 
Electron microscopy 518 
Overnight cultures grown at 37°C were diluted 1:200 into 40 ml of fresh TSB and grown 519 
at 30°C or 37°C to an OD600 of 0.5. Bacteria from a 10-ml culture aliquot were collected 520 
by centrifugation at 8,000 x g, and the cell pellets were suspended in fixation solution 521 
(2.5% glutaraldehyde in 0.1 M cacodylate buffer [pH 7.4]; Electron Microscopy 522 
Sciences, PA) and incubated overnight at 4°C. The fixed cells were further treated with 523 
2% osmium tetroxide, followed by 0.25% uranyl acetate for contrast enhancement. The 524 
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pellets were dehydrated in increasing concentrations of ethanol, followed by pure 525 
propylene oxide, and then embedded in Epon resin. Thin sections for electron 526 
microscopy were stained with lead citrate and observed in a Philips CM100 BioTWIN 527 
transmission electron micro- scope fitted with an Olympus Veleta camera with a 528 
resolution of 2,048 by 2,048 pixels. Sample processing and microscopy were performed 529 
at the Center for Integrated Microscopy, Faculty of Health and Medical Sciences, 530 
University of Copenhagen. 531 
 532 
Peptidoglycan analysis 533 
One (for the wild type and the 564-25-2 mutant) or two liters (for the clpX mutant) of 534 
TSB medium was inoculated with overnight cultures of S. aureus strains SA564, 535 
SA564ΔclpX and strain 564-25-2, to an OD600 of 0.06 and grown at 30°C to late-log 536 
phase (OD approximately 1.6 for the wild type and strain 564-25-2, and 0.8 for the clpX 537 
strain). The cultures were cooled on ice and the bacteria were subsequently collected 538 
by centrifugation. Peptidoglycan was purified, digested with mutanolysin, and analyzed 539 
by high-performance liquid chromatography (HPLC), as described previously (7). 540 
Muropeptide profiles were determined for each strain in duplicate, and HPLC 541 
chromatograms from one representative experiment are shown. Data analysis was 542 
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Table 1: Number of transductants harboring either the wild-type or the ΔclpX 548 
allele when using different S. aureus recipient strains 549 
 Phage transduction recipient 
Co-transduction of 











Yes 13 0 0 12 0 
No 3 12 11 2 10 
1Replacement of the ΔclpX allele with the wild-type allele was assessed by PCR. 550 
Table 2: MICs (mg/L) for different antibiotics of clpX and clpX ltaS mutants in 551 
SA564 and 8325-4 552 
Antibiotic 
8325-4 SA564 
WT clpX clpX 
ltaS382* 
wt clpX clpX 
ltaSH476Q 
Oxacillin 0.19-0.25 0.38 - 0.5 0.094 0.38-0.5 1.5 - 4 0.25 
Imipenem 0.047 0.047 0.032 0.064 0.064 0.023 
Ertapenem 0.19 0.19 0.094 0.19 0.25 0.19 
Cefoxitin 3 3 0.38 4 4 1 
Daptomycin 0.38-0.75 0.75 - 1 0.38  0.25 0.38 0.38 
Vancomycin 1.5 1.5 0.25 1.5 1 0.19 
 553 
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Figure legends 554 
Fig 1: ClpX is required for growth at low temperatures in S. aureus. 555 
A. ClpX is required for growth at low but not high temperatures. The wild-type S. aureus 556 
strain SA564 and the indicated derivatives were grown in TSB at 37°C. At OD600 = 0.5, 557 
the cultures were diluted 101, 102, 103 and 104-fold, and 5 μL of each dilution was 558 
spotted on TSA plates that were subsequently incubated at the indicated temperatures. 559 
B. The clpX-related growth defect can be complemented. The wild-type S. aureus strain 560 
SA564 and the corresponding clpX mutant harboring either a plasmid expressing ClpX 561 
under an anhydrotetracycline (AHT)-inducible promoter (pKB1469), or the empty vector, 562 
were grown in TSB at 37°C and diluted 101, 102, 103, 104 and 105-fold. Five μL of each 563 
dilution was spotted on TSA plates containing 25 ng/ml AHT that were subsequently 564 
incubated at 30°C. C..Growth rates of wild-type and mutant strains at 30°C and 37°C. 565 
Cultures of SA564, JE2, or Newman strains and their corresponding clpX and clpP 566 
mutants were grown overnight at 37°C, diluted into 300 μl TSB, and growth was 567 
measured at 30°C in a Bioscreen C instrument. Values represent mean specific growth 568 
rates (h-1) +/- the standard deviation of at least three biological replicates. Numbers 569 
above each bar indicate mean doubling time in minutes. Statistically significant 570 
differences between each mutant and the wild types, or between the two mutants (as 571 
indicated by the horizontal bar) are indicated with asterisks (* p < 0.05; ** p < 0.001).  D. 572 
Final CFU/ml yield at 30°C and 37°C. Overnight cultures of SA564 and the indicated 573 
mutant strains were diluted 1:200 in TSB and grown at the indicated temperature for 24 574 
h. Cultures were diluted, plated and incubated at 37°C. Values represent mean CFU/ml 575 
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+/- the standard deviation of at least three biological replicates. Statistically significant 576 
differences between each mutant and the wild type, or between the two mutants (as 577 
indicated by the horizontal bar) are indicated with asterisks (* p < 0.05; ** p < 0.001). E. 578 
Growth curve of clpX clpP double mutant. S. aureus strain 8325-4 and corresponding 579 
clpX, clpP, and clpX clpP strains were grown overnight at 37°C, and diluted into 300 μl 580 
TSB, and growth was measured at 30°C in a Bioscreen C instrument. Values represent 581 
mean OD readings +/- the standard deviation (error bars are smaller than the symbol 582 
size) of three biological replicates. 583 
Fig 2: Spontaneous suppressor mutants restore growth of the S. aureus clpX 584 
mutant 585 
A. Faster growing suppressor mutants appear spontaneously in clpX cultures grown at 586 
low temperature. An overnight culture of the S. aureus SA564 clpX mutant was grown at 587 
30°C in TSB, diluted and spread on a TSA plate, and incubated at 30°C for 48 hours. B. 588 
Growth of the S. aureus SA564 wild-type strain, the SA564 clpX strain, and the 589 
spontaneous suppressor strain 564-25-2 (ltaSH476Q) at 30°C in TSB measured as 590 
CFU/ml. Colony formation was assessed by incubating plates for 48 hours at 30°C. 591 
‘clpX small’ indicate the count of small, normal-sized, colonies, and ‘clpX large’ indicate 592 
the count of large suppressor colonies. Values represent mean of three replicates, and 593 
error bars indicate standard deviation. 594 
Fig 3: Mutations in the ltaS gene restore growth of the S. aureus clpX mutant 595 
A. Topology map of LtaS showing the location and class of the identified suppressor 596 
mutations. B. Analysis of LTA synthesis. Extracts obtained from S. aureus strains 597 
 31
SA564 wild-type, SA564 clpX, SA564 clpP, 564-25-2 (SA564 clpX ltaSH476Q), 8325-4 598 
wild-type, 8325-4 clpX, and 83-25C (clpX ltaS382STOP) grown at 30°C and normalized 599 
based on optical density (OD600) readings of the original cultures were separated by 600 
SDS/PAGE, electrotransferred to a PVDF membrane, and subjected to immunoblotting 601 
using an LTA-specific or an LtaS-specific antibody as indicated. C. Growth of the S. 602 
aureus SA564 wild-type strain, the SA564 clpX strain, the spontaneous suppressor 603 
strain 564-25-2 (SA564 clpX ltaSH476Q), and the SA564 clpX ltaS::erm strain at 30°C in 604 
TSB. D. LtaS is essential at 37°C but not at 30°C. The 8325-4 clpX ltaS382STOP 605 
suppressor mutant harboring either a plasmid expressing ClpX under an AHT-inducible 606 
promoter, or the empty vector, were grown in TSB at 37°C and diluted 101, 102, 103 and 607 
104-fold. 10 μL of each dilution was spotted on TSA plates supplemented with AHT as 608 
indicated and subsequently incubated at either 30°C or 37°C. 609 
Fig 4: Cyclic-di-AMP levels in S. aureus are not affected by inactivation of clpX or 610 
clpP. 611 
Intracellular c-di-AMP concentration. The concentration of c-di-AMP in the cytoplasm of 612 
the indicated strains were determined by LC-MS/MS. Values indicate c-di-AMP/mg 613 
bacterial dry weight, and the average and standard deviation of three replicates are 614 
plotted. 615 
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Fig 5: Cell morphology, septum formation and cell wall structure is affected by 616 
inactivation of clpX and by the compensatory loss of LtaS activity. 617 
A. Fluorescence microscopic analysis of wild-type, clpX inactivated, and LTA depleted 618 
strains. S. aureus strain 8325-4 and its corresponding clpX, and clpX-ltaSSTOP mutants 619 
were grown in TSB to exponential phase at 37°C. Strains 8325-4 iltaS and 8325-4 clpX-620 
iltaS were grown to exponential phase at 37°C in the presence of 1 mM IPTG, then 621 
diluted into medium with or without 1 mM IPTG and grown for 3 h at 37°C. Bacteria 622 
were stained with BODIPY-vancomycin and prepared for fluorescence microscopy as 623 
described in materials and methods. Examples of raw microscope images can be seen 624 
in Fig. S4-S7. B. TEM analysis of wild-type, clpX inactivated, and LTA-negative strains. 625 
The SA564 wild type, the SA564 clpX strain, and the 564-25-2 (SA564 clpX ltaSH476Q) 626 
strain were grown in TSB to log-phase at 37°C, and prepared for electron microscopy 627 
as described in materials and methods. C. Peptidoglycan structure in SA564 wild type, 628 
the SA564 clpX strain, and the 564-25-2 (SA564 clpX ltaSH476Q) strain. HPLC 629 
chromatograms of mutanolysin digested peptidoglycan purified from the indicated 630 
strains, and percentages indicating the relative abundance of monomers, dimers, 631 
trimers to 8-mers, and higher oligomers, respectively in each strain. Representative 632 
results of two individual experiments are shown. 633 
Fig 6: An LTA-negative strain has decreased autolytic activity 634 
A. Autolysis assay. S. aureus strain SA564 and the corresponding clpX, clpP and clpX 635 
ltaSH476Q mutants were analyzed for autolytic activity using a Triton X-100 autolysis 636 
assay. B. Zymogram assay. SA564 and its derived strains were grown to exponential 637 
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phase, and equal amounts of cell wall-associated proteins from were loaded onto an 638 
SDS polyacrylamide gel containing heat-killed S. aureus SA564 wild-type cells. 639 
Representative results of three independent experiments are shown. The positions of 640 
the molecular mass standards are indicated on the left (in kilodaltons). Atl and Sle1 641 
protein levels were quantified relative to the wild-type strain using ImageJ.  642 
  643 
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Supplementary figure legends: 644 
Fig. S1. Effect of size and growth phase of inoculum on growth of clpX mutant. S. 645 
aureus strains 8325-4 and 8325-4 clpX were grown to exponential (OD ~0.1; “exp”) or 646 
stationary (overnight culture; “stat”) phase at 37°C, diluted as indicated (1:10 or 1:1000) 647 
into 300 μl TSB, and growth was measured at 30°C in a Bioscreen C instrument. Values 648 
represent mean OD readings +/- the standard deviation (error bars are smaller than the 649 
symbol size) of three biological replicates. 650 
Fig. S2. Microscopic analysis of wild type, clpX inactivated, and LTA-negative strains. 651 
S. aureus SA564 wild type, the SA564 clpX strain, and the 564-25-2 (SA564 clpX 652 
ltaSH476Q) strain were grown in TSB to log-phase at either 30°C or 37°C, samples were 653 
prepared for microscopy analysis, and bacteria stained with BODIPY-vancomycin. Left 654 
panels show phase contrast images, right panels show fluorescence images.  655 
Fig. S3. A. Growth curves of S. aureus 8325-4 and derived strains. Overnight cultures 656 
of S. aureus strains 8325-4 (WT), 8325-4-ΔclpX, 8325-4-ΔclpX ltaSstop, 8325-4-iltaS 657 
(WT-iltaS) and 8325-4ΔclpX-iltaS were harvested, washed, and diluted 1:1000 into TSB 658 
substituted with 1 mM IPTG. Cultures were incubated at 37°C, and OD600 values were 659 
recorded. To maintain the cultures in log phase, at the 4 h time point the cultures were 660 
back diluted 1:100 into 5 ml fresh TSB (when required substituted with 1 mM IPTG) and 661 
growth continued for an additional 4 hours. The average OD600 values and standard 662 
deviations from three independent experiments are plotted. B. Analysis of LTA 663 
synthesis. Extracts obtained from S. aureus strains 8325-4 (WT), 8325-4-ΔclpX, 8325-4-664 
ΔclpX ltaSstop, 8325-4-iltaS (WT-iltaS) and 8325-4ΔclpX-iltaS were separated by 665 
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SDS/PAGE, electrotransferred to a PVDF membrane, and subjected to immunoblotting 666 
using an LTA-specific antibody. 667 
Fig. S4. Fluorescence microscopic analysis of strain 8325-4 iltaS grown to exponential 668 
phase at 37°C in the presence of 1 mM IPTG, and stained with BODIPY-vancomycin. 669 
Bacteria were grown and prepared for fluorescence microscopy as described in 670 
materials and methods. 671 
Fig. S5. Fluorescence microscopic analysis of strain 8325-4 clpX iltaS grown to 672 
exponential phase at 37°C in the presence of 1 mM IPTG, and stained with BODIPY-673 
vancomycin. Bacteria were grown and prepared for fluorescence microscopy as 674 
described in materials and methods. 675 
Fig. S6. Fluorescence microscopic analysis of strain 8325-4 iltaS grown to exponential 676 
phase at 37°C in the absence of IPTG, and stained with BODIPY-vancomycin. Bacteria 677 
were grown and prepared for fluorescence microscopy as described in materials and 678 
methods. 679 
Fig. S7. Fluorescence microscopic analysis of strain 8325-4 clpX iltaS grown to 680 
exponential phase at 37°C in the absence of IPTG, and stained with BODIPY-681 
vancomycin. Bacteria were grown and prepared for fluorescence microscopy as 682 
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